Alexandre Theron Shares The Proposals from SFTH on the Implementation of Prophylactic Treatments in Children With Hemophilia
Alexandre Theron, Head of the Pediatric Bone Marrow Transplant and Cell Therapy Unit at CHU Montpellier, shared on LinkedIn:
”We are pleased to announce the publication of the proposals of the SFTH (French Society of Thrombosis and Hemostasis) Paediatricians’ Club on the implementation of prophylactic treatments in children with hemophilia in 2025.
Work carried out with:
Olivia Pineau, Sandrine Meunier, Bayart Sophie, Caroline Oudot and all the members of the club and the support of the SFTH”
Read the full article here.
Article: How to start prophylaxis in untreated children with severe and moderate haemophilia in 2025, opinion of paediatricians from the French Society of Thrombosis and Haemostasis
Authors: Alexandre Theron, Olivia Pineau, Sophie Bayart, Caroline Oudot, Sandrine Meunier
Stay updated on all scientific advances in the field of hemophilia with Hemostasis Today.
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial